Upcoming events

There are no upcoming events at this time.

All events


thromboDx acquires a new EUROSTARS grant

Posted on

Amsterdam, The Netherlands – thromboDx, the molecular diagnostics company that develops and commercializes blood-based diagnostics through its proprietary platelet-powered technology platform, announces that is has received another EUROSTARS grant. Focusing on the development of companion diagnostics for therapy monitoring of lung cancer patients, thromboDx decided to lead a consortium and submit a proposal under the…


All-in-one cancer diagnostics platform

Posted on

thromboDx collaborators show Blood Platelets offer all-in-one cancer diagnostics platform; study published in Cancer Cell   Amsterdam, 29th October 2015: thromboDx, a molecular diagnostic company based in Amsterdam, The Netherlands announced that a 283 subject study shows that its’ blood platelet based diagnostic platform enables accurate detection, classification and subtyping of cancer in the equivalent…


thromboDx pitching at Falling Walls 2014

Posted on

Amsterdam – thromboDx announces that is has been nominated and elected to be one of the 28 young startup companies pitching at the international Falling Walls conference in Berlin on November 8 and 9. The 2014 edition of Falling Walls Conference marks the 25th anniversary of the falling of the Berlin Wall in 1989. The…


Dr. Tom Würdinger awarded Galenus Prize 2014

Posted on

Dr. Tom Würdinger, Chief Scientific Officer of thromboDx was awarded the Galenus Research Prize 2014. He received the € 5,500 award and a golden medal from Dr. René Bernards, founder of biotech firm Agendia. The award ceremony took place during the Dutch Medicines Days 2014 in Ede, NL. Würdinger was selected by the jury for…

Read all the news >


'We are interested in developing partnerships with companies who wish to license, co-develop, and/or commercialize platelet-powered diagnostics tests'

Contact Us